홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

2-Methylpiperazine, (R)- → 8-(hydroxymethyl)-2-[4-[(3R)-3-methylpiperazin-1-yl]phenyl]chromen-4-one

HRID 605
인쇄

반응식

HRID 605 반응식
CC(=O)OCc1cccc2c(=O)cc(-c3ccc(Br)cc3)oc12.C[C@@H]1CNCCN1>CC(=O)O.CC(=O)O.Cc1ccccc1.O=C([O-])[O-].[Cs+].[Cs+].[Pd].c1ccc(P(c2ccccc2)c2ccc3ccccc3c2-c2c(P(c3ccccc3)c3ccccc3)ccc3ccccc23)cc1>C[C@@H]1CN(c2ccc(-c3cc(=O)c4cccc(CO)c4o3)cc2)CCN1
참가 물질반응 조건실험 절차출처 및 근거반응 노트

참가 물질

7

반응물 2

HCID 73304342-Methylpiperazine, (R)-HCID 134844211[2-(4-Bromophenyl)-4-oxochromen-8-yl]methyl acetate

생성물 1

HCID 1325313348-(hydroxymethyl)-2-[4-[(3R)-3-methylpiperazin-1-yl]phenyl]chromen-4-one수율 13.31%

시약·촉매·용매 4

HCID 10796Cesium carbonate시약HCID 634876Binap, (A+-)-
촉매
HCID 4144353Palladium (II) acetate촉매
HCID 1140Toluene용매

반응 조건

온도
110 °C

실험 절차

diacetoxypalladium (6.02 mg, 0.03 mmol) was added to a degassed mixture of (2-(4-bromophenyl)-4-oxo-4H-chromen-8-yl)methyl acetate (200 mg, 0.54 mmol), 2,2'-bis(diphenylphosphino)-1,1'-binaphthalene (25.03 mg, 0.04 mmol) and cesium carbonate (244 mg, 0.75 mmol) in toluene (5 mL). The resulting suspension was stirred at 110 °C for 3 hours under nitrogen (see note 1). More diacetoxypalladium (6.02 mg, 0.03 mmol) was added and the reaction mixture was heated to 110°C for 1 hour and again could see no product. TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (4.91 mg, 5.36 µmol) and 2,2'-bis(diphenylphosphino)-1,1'-binaphthalene (25.03 mg, 0.04 mmol) were added and the reaction mixture was heated to 110°C for 1 hour and again could see no product. sodium 2-methylpropan-2-olate (61.8 mg, 0.64 mmol) was added and the reaction mixture was heated to 110°C for 1 hour where a small amount of product could be detected by LCMS and significant dehalogenation. The reaction mixture was allowed to cool to room temperature The crude product was purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 7M NH3/MeOH and fractions were evaporated to dryness to afford crude product. The crude product was purified by flash silica chromatography, elution gradient 0 to 5% 7N NH3/MeOH in DCM. Fractions were evaporated to dryness to afford product that was not pure. The sample was dissolved in DMF (4ml) and the crude product was purified by preparative HPLC (Waters XBridge Prep C18 OBD column, 5µ silica, 30 mm diameter, 100 mm length), using decreasingly polar mixtures of water (containing 1% NH3) and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness to afford (R)-8-(hydroxymethyl)-2-(4-(3-methylpiperazin-1-yl)phenyl)-4H-chromen-4-one (25.00 mg, 13.31 %) as a yellow solid.

출처 및 근거

ORD 기록
ord-ea023f46022d4035acdf5a18572a2571
출처 데이터셋
750 AstraZeneca ELN dataset
원본 링크
출처 보기

반응 노트

이 페이지에서참가 물질반응 조건실험 절차출처 및 근거반응 노트